Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Philip Miller

Anesthesiologist Assistant Atlanta, GA Physician Assistant

NPI 1841301124 CMS profile 11014829

95 Collier Rd Nw, Suite 5015, Atlanta, GA 30309

Open in the dashboard

General payments

$1,054

26 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Philip Miller of Atlanta, GA is reported in the CMS Open Payments database as having received $1,054 across 26 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Anesthesiologist Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $189 4
2024 General $179 2
2023 General $240 9
2022 General $248 5
2021 General $197 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Miller
  • Anesthesiologist Assistant median
  • Middle half of Anesthesiologist Assistant
  • National median

In program year 2025, general payments to Philip Miller were reported at $189. Among 1,532 Anesthesiologist Assistant profiles paid that year, the median was $35 and the middle half received between $20 and $63.

Show as a table
Year Philip Miller Anesthesiologist Assistant median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $197 $25 $16–$45 $132
2022 $248 $31 $18–$58 $149
2023 $240 $38 $20–$73 $160
2024 $179 $42 $21–$78 $164
2025 $189 $35 $20–$63 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Maquet Cardiovascular U.S. Sales, L.L.C. $396 11 payments
  2. Abbott Laboratories $335 5 payments
  3. bioMerieux $167 1 payment
  4. Atricure, Inc. $58 3 payments
  5. Ge Healthcare $22 1 payment
  6. KCI USA, Inc $19 1 payment
  7. Lsi Solutions Inc $17 1 payment
  8. La Jolla Pharmaceutical Company $16 1 payment
  9. HemoSonics LLC $12 1 payment
  10. LeMaitre Vascular, Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $887 25 payments
  2. Consulting Fee $167 1 payment
Products named General payments · program years 2021–2025
  1. Vasoview Hemopro 2 Cardiology/Vascular Diseases $246 9 payments
  2. NephroCheck Test Kit $167 1 payment
  3. NAVITOR $150 1 payment
  4. VASOVIEW HEMOPRO 2 Cardiovascular Care $118 1 payment
  5. MitraClip System $115 1 payment
  6. HeartMate Touch $42 2 payments
  7. SYNERGY ABLATION SYSTEM $40 2 payments
  8. CARDIOROOT $33 1 payment
  9. CARDIOMEMS $29 1 payment
  10. AtriCure cryoICE cryoSPHERE Cryoablation System $21 1 payment
  11. Other $106 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Prescriptions dispensed, refills included

Drug cost

$91

Paid at the pharmacy, in all

Branded share of claims

0%

Brand-name drugs, not generics

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Warfarin Sodium Generic 12 $91

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$1,473

Medicare's payments for the services billed

Medicare patients

16

Average age 73

Services billed

16

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

26 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiologist Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record